Trial Profile
COMPETITION: Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms COMPETITION
- Sponsors Takeda Global Research and Development Center
- 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
- 09 Oct 2008 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 09 Oct 2008 Actual patient number (628) added as reported by ClinicalTrials.gov.